Boston Scientific seeks EU clearance for $14.5bn Penumbra deal
Boston Scientific has asked the EU merger regulator to approve its $14.5 billion acquisition of rival US biomedical company Penumbra. The European Commission has set a deadline of Dec. 4 to...To view the full article, register now.
Already a subscriber? Click here to view full article